Leerink Partners Reiterates a Buy Rating on Ardent Health Partners (ARDT)

Ardent Health Partners, Inc. (NYSE:ARDT) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. Leerink Partners analyst Whit Mayo reiterated a Buy rating on Ardent Health Partners, Inc. (NYSE:ARDT) on July 5 without a price target.

The rating continued the analyst’s bullish streak on the company, as he gave it a buy rating on June 23 due to strong sector trends and the belief that the company is presently underperforming its potential. The analyst stated that Ardent Health Partners, Inc. (NYSE:ARDT) has a strong outpatient network strategy with potential for growth.

Mayo further reasoned that despite the delay in the anticipated $65 million NM DPP contribution to Q3 2025, the company’s full-year EBITDA remains unaffected, attributing the delay to uncertainty in the timing of CMS approval instead of a lack of confidence in the eventual approval.

Ardent Health Partners, Inc. (NYSE:ARDT) is a provider of healthcare and related services. The company is headquartered in Brentwood, TN, and also owns and operates hospitals through its subsidiaries.

While we acknowledge the potential of ARDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.